SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: Ricardo A. Biondi who wrote (510)11/21/1997 9:00:00 AM
From: Apple Jacks  Read Replies (1) | Respond to of 998
 
The FDA does have a home page, but it is quite extensive and I don't know exactly where the information would be. The home page is www.fda.gov/cder/

I am bullish on Cephalon too, but have lost money on expired calls due to the delays. I haven't decided whether I should pursue this stock with some May or June calls (which you would think would be enough time).

I also think the company didn't have to wait to Nov.11 to withdraw and resubmit their NDA. They must have known they were going to pull that stunt well in advance of the Nov. 11th date.

Signed,

Bullish but somewhat disillusioned



To: Ricardo A. Biondi who wrote (510)11/23/1997 2:39:00 PM
From: Jeffers Hughes  Read Replies (1) | Respond to of 998
 
RAB,
Here is the address: fda.gov, where you can obtain the latest notice about FDA advisary meeting. Good luck.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News